Results 151 to 160 of about 1,311 (180)

Autologous Hematopoietic Stem Cell Transplantation for Childhood Autoimmune Disease

Pediatric Clinics of North America, 2010
Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) can be used in the management of patients with autoimmune disorders. Experience gained in adults has helped to better define the conditioning regimens required and appropriate selection of patients who are most likely to benefit from autologous HSCT.
Francesca, Milanetti, Mario, Abinun, Julio C, Voltarelli, Richard K, Burt   +3 more
openaire   +2 more sources

Hyperthyroidism as a latent complication of autologous hematopoietic stem cell transplantation

International Journal of Hematology, 2008
Thyroid dysfunction after hematopoietic stem cell transplantation has been investigated in many studies. Most post-transplant thyroid disorders such as hypothyroidism are recognized as a late complication whilst hyperthyroidism is infrequent and transient, and usually happens early at the onset after transplant.
Yin-Hsun, Feng, Bo-An, Su, Cheng-Yao, Lin, Wen-Tsung, Huang, Chao-Jung, Tsao   +4 more
openaire   +2 more sources

Autologous Hematopoietic Stem Cell Transplantation for Type 1 Diabetes

Annals of the New York Academy of Sciences, 2008
In this review, we present (1) the scientific basis for the use of high‐dose immunosuppression followed by autologous peripheral blood hematopoietic stem cell transplantation for newly diagnosed type 1 diabetes (T1D); (2) an update of the clinical and laboratory outcome of 20 patients transplanted at the University Hospital of the Ribeirão Preto ...
Júlio C, Voltarelli, Carlos E B, Couri, Ana B P L, Stracieri, Maria C, Oliveira, Daniela A, Moraes, Fabiano, Pieroni, George M N, Barros, Maria Isabel A, Madeira, Kelen C R, Malmegrim, Maria C, Foss-Freitas, Belinda P, Simões, Milton C, Foss, Elizabeth, Squiers, Richard K, Burt   +13 more
openaire   +2 more sources

Autologous Hematopoietic Stem Cell Transplantation in Non-Hodgkin’s Lymphomas

Acta Haematologica, 2005
Early studies on high-dose therapy followed by autologous bone marrow transplantation demonstrated the safety and efficacy of this approach in non-Hodgkin’s lymphoma (NHL). As the procedure became easier and safer with the introduction of peripheral blood progenitor cells instead of marrow, the popularity of this procedure declined. In the last decade,
openaire   +3 more sources

The role of autologous hematopoietic stem cell transplantation in hematologic malignancy

Current Opinion in Oncology, 1994
Supraintensive cytoreductive therapy with hematopoietic stem cell rescue (HSCR) is able to provide curative therapy in a number of hematologic malignancies. Allogeneic HSCR is limited to less than 50% of patients because of the absence of related or unrelated compatible donors.
openaire   +2 more sources

Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis

Multiple Sclerosis Journal, 2021
Claudia Massarotti, Elvira Sbragia, Giacomo Boffa   +2 more
exaly  

Autologous hematopoietic stem cell transplantation for multiple sclerosis: A current perspective

Multiple Sclerosis Journal, 2021
Gauruv Bose, Simon Thebault, Harold Atkins   +2 more
exaly  

Immune Reconstitution After Autologous Hematopoietic Stem Cell Transplantation

Mayo Clinic Proceedings, 2001
Luis F Porrata, Mark R Litzow
exaly   +2 more sources

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis

Therapeutic Advances in Neurological Disorders, 2020
Jan Lycke
exaly  

Sarcopenia Predicts Inferior Progression-Free Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation

Transplantation and Cellular Therapy, 2023
Nuttavut Sumransub, Qing Cao, Brian C Betts   +2 more
exaly